Why did net income fall so much more than adjusted earnings?

GAAP net income is affected by items MetLife excludes from adjusted earnings, most notably net derivative losses of $796 million in the quarter, driven by stronger equity markets and higher long-term interest rates. Those losses, together with $273 million of net investment losses, pushed GAAP results down 23%, compared with a 16% decline in adjusted earnings.

What drove the decline in adjusted earnings this quarter?

The main drivers were less favorable underwriting across life and non-medical health in Group Benefits, lower recurring interest margins in RIS, and lower variable investment income from weaker private equity returns. Asia also declined on investment and underwriting margins. Volume growth and favorable expense margins partly offset these pressures.

Are the revenue trends healthy despite the 6% decline in reported premiums, fees and other revenues?

Much of the reported decline reflects lower pension risk transfer (PRT) volume. Excluding PRT, adjusted PFOs rose 5% to $12.4 billion, with growth in every segment except MetLife Holdings, which is running off. Investors should still watch PRT, which is lumpy and can distort headline revenue trends.

What does the filing say about capital return and balance sheet strength?

MetLife returned about $900 million in the quarter through share repurchases and common dividends, including $510 million in buybacks and $382 million in common dividends. Holding company cash and liquid assets were $5.2 billion, the U.S. statutory adjusted capital was an estimated $17.1 billion, and the Japan solvency margin ratio was about 710%.

Does this 8-K include new guidance or any notable one-time items?

The 8-K does not include new forward guidance; it furnishes the earnings release, financial supplement, AUM fact sheet and supplemental slides, and points to the August 7, 2025 earnings call for discussion. Total notable items were zero in the quarter, so the adjusted results were not affected by one-time items that MetLife chose to exclude.

METLIFE INC 8-K: Earnings & Results & Regulation FD

01—Abstract

Summary

Summary of the 8-K filed August 6, 2025. Cited figures are marked; the original filing is the authoritative source.

MetLife's 2Q25 results (reported August 6, 2025) show a mixed quarter: the headline GAAP net income fell 23% to $698 million^a ($1.03 per share), while adjusted earnings, the company's preferred measure of underlying performance, declined 16% to $1.36 billion ($2.02 per share).

The main drags were less favorable underwriting in Group Benefits, lower recurring interest margins in RIS, and sharply lower variable investment income, which fell to $195 million^b on weaker private equity returns. Net derivative losses of $796 million, driven by stronger equity markets and higher long-term rates, were the largest contributor to the GAAP decline. Adjusted premiums, fees and other revenues excluding pension risk transfers (PRT) grew 5% to $12.4 billion, and most segments other than MetLife Holdings showed growth.

The quarter also showed underlying strength in several franchises. EMEA adjusted earnings rose 30% on volume growth, Latin America's constant-currency adjusted earnings rose 15%, and Asia sales increased 9% on a constant-currency basis, led by Japan and Korea. Book value per share rose 7% to $35.79^c and adjusted book value per share rose 6% to $56.23.

MetLife returned roughly $900 million^d to shareholders in the quarter through buybacks and dividends, and holding company cash and liquid assets stood at $5.2 billion. Management also reiterated progress on the Chariot Re, Talcott Financial Group and PineBridge Investments transactions, which it says are meant to accelerate growth in asset management and the retirement platform. For investors, the key questions are whether the decline in variable investment income and Group Benefits underwriting is cyclical or structural, and how quickly the announced strategic transactions can add earnings.

The filing also shows that the Q2 direct expense ratio of 11.7% (excluding PRT and notable items) was below MetLife's 12.1% annual target, and that no notable items were recorded this quarter. The 8-K furnishes these materials rather than filing them, and the detailed results will be discussed on the August 7, 2025 earnings call.

02—Key points

Key Highlights

GAAP net income fell 23% to $698 million ($1.03 per share), mainly due to $796 million in net derivative losses and lower adjusted earnings.
Adjusted earnings declined 16% to $1.36 billion ($2.02 per share), with Group Benefits down 25% on less favorable underwriting and RIS down 10% on lower recurring interest margins.
Adjusted premiums, fees and other revenues excluding PRT rose 5% to $12.4 billion, while total reported PFOs fell 6% to $12.7 billion because of lower pension risk transfer volume.
Variable investment income fell 35% to $195 million, driven by lower private equity returns, which is a key earnings volatility driver.
Book value per share rose 7% to $35.79 and adjusted book value per share rose 6% to $56.23; ROE was 11.7% (GAAP) and adjusted ROE was 14.6%.
EMEA adjusted earnings rose 30% and Latin America adjusted earnings rose 15% on a constant-currency basis, while Asia adjusted earnings fell 22% on less favorable investment and underwriting margins.
MetLife returned about $900 million to shareholders in the quarter and held $5.2 billion in holding company cash and liquid assets; year-to-date buybacks were about $2.1 billion.

03—Questions

Frequently Asked Questions

Why did net income fall so much more than adjusted earnings?
GAAP net income is affected by items MetLife excludes from adjusted earnings, most notably net derivative losses of $796 million in the quarter, driven by stronger equity markets and higher long-term interest rates. Those losses, together with $273 million of net investment losses, pushed GAAP results down 23%, compared with a 16% decline in adjusted earnings.
What drove the decline in adjusted earnings this quarter?
The main drivers were less favorable underwriting across life and non-medical health in Group Benefits, lower recurring interest margins in RIS, and lower variable investment income from weaker private equity returns. Asia also declined on investment and underwriting margins. Volume growth and favorable expense margins partly offset these pressures.
Are the revenue trends healthy despite the 6% decline in reported premiums, fees and other revenues?
Much of the reported decline reflects lower pension risk transfer (PRT) volume. Excluding PRT, adjusted PFOs rose 5% to $12.4 billion, with growth in every segment except MetLife Holdings, which is running off. Investors should still watch PRT, which is lumpy and can distort headline revenue trends.
What does the filing say about capital return and balance sheet strength?
MetLife returned about $900 million in the quarter through share repurchases and common dividends, including $510 million in buybacks and $382 million in common dividends. Holding company cash and liquid assets were $5.2 billion, the U.S. statutory adjusted capital was an estimated $17.1 billion, and the Japan solvency margin ratio was about 710%.
Does this 8-K include new guidance or any notable one-time items?
The 8-K does not include new forward guidance; it furnishes the earnings release, financial supplement, AUM fact sheet and supplemental slides, and points to the August 7, 2025 earnings call for discussion. Total notable items were zero in the quarter, so the adjusted results were not affected by one-time items that MetLife chose to exclude.

04—Continue

← View all 8-K filings